Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Treasury Shares (2016 - 2025)

Conmed (CNMD) has disclosed Treasury Shares for 16 consecutive years, with $12.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 17.53% year-over-year to $12.9 million, compared with a TTM value of $12.9 million through Dec 2025, down 17.53%, and an annual FY2025 reading of $12.9 million, down 17.53% over the prior year.
  • Treasury Shares was $328097.0 for Q4 2025 at Conmed, down from $344143.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.2 million in Q1 2021 and bottomed at $328097.0 in Q4 2025.
  • Average Treasury Shares over 5 years is $909452.0, with a median of $558850.5 recorded in 2023.
  • The sharpest move saw Treasury Shares crashed 60.86% in 2022, then increased 18.02% in 2024.
  • Year by year, Treasury Shares stood at $54.1 million in 2021, then tumbled by 57.86% to $22.8 million in 2022, then crashed by 34.2% to $15.0 million in 2023, then grew by 4.27% to $15.6 million in 2024, then fell by 17.53% to $12.9 million in 2025.
  • Business Quant data shows Treasury Shares for CNMD at $12.9 million in Q4 2025, $13.5 million in Q3 2025, and $13.9 million in Q2 2025.